Brilaroxazine
Brilaroxazine (RP5063) is a multimodal dopamine and serotonin modulator, acting as a partial agonist at D2, D3, D4, 5-HT1A, and 5-HT2A receptors and an antagonist at 5-HT2B and 5-HT7 receptors. Its pharmacological profile supports research into cognitive deficits associated with schizophrenia and Parkinson's disease, as evidenced in preclinical in vivo models.
Product Specifications
CAS Number
1239729-06-6
Product Name Alternative
Syndrome, ADHD, RP5063, RP-5063, RP 5063, Pulmonary, Serotonin Receptor, 5-HT7 Receptor, 5-HT7, 5HT Receptor, 5-hydroxytryptamine Receptor, 5HTReceptor, Alzheimer, 5-HT1A Receptor, 5-HT2B Receptor, 5-HT2A Receptor, 5-HT2B, 5-HT2A, 5-HT1A, 5-HT Receptor, autism, arterial, cardiac, DopamineReceptor, Dopamine Receptor, disorder, Tourette, depressive, D4 receptor, D4 Receptor, D2 receptor, D2 Receptor, D3 Receptor, D3 receptor, Brilaroxazine, Inhibitor, hypertension, inhibit, PAH, Parkinson
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
98.00% (May vary between batches)
Solubility
DMSO:95 mg/mL (210.94 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.33 mM)
Smiles
Clc1cccc (N2CCN (CCCCOc3ccc4OCC (=O) Nc4c3) CC2) c1Cl
Molecular Formula
C22H25Cl2N3O3
Molecular Weight
450.36
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
248709-ML650 100 µL
MGAT4A (mannosyl (alpha-1,3-) -Glycoprotein beta-1,4-N-acetylglucosaminyltransferase, Isozyme A, GNT-IV, GNT-IVA) (MaxLight 650)
Sign In for Pricing
View Details 
FAB93252MFV610 0.1 mL
Mouse Monoclonal ADAM28 Antibody (1004266) [mFluor Violet 610 SE]
Sign In for Pricing
View Details 